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Introduction
The origin of cancer in the humans is considered to be a
complex and multistep process. In all cases, however, the
cancer cell contains a genome in which gene(s) are either
altered or wrongly expressed. Therefore, alterations in
DNA have been thought to be a crucial first step (initia-
tion) in the long chain of events leading to cancer.
The occurrence of DNA lesions in cells in the human
body is not a rare phenomenon. They can occur due to
exposure to many exogenous agents present in our food,
environment, and occupational situations. A major addi-
tional cause of DNA damage in cells is the action of
endogenous factorsliketheintermediates ofmetabolicand
detoxifying processes in our body (1). In toto the human
body contains about 1014 cells; endogenous factors alone
may induce around 4000 DNA lesions/day/cell, i.e.,
4 x 1017DNAlesions/body/day. Sincethefrequencyofthe
transformation of cells into cancerous ones in the body is
orders of magnitude lower than that of the formation of
DNA lesions, it is obvious that only a limited number of
DNA lesions are related to the process of neoplastic
transformation. Some of the DNA lesions in cells may be
converted to DNA sequence alterations (i.e., mutations),
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but still the number of DNA alterations is considerably
greater than the number of cells that are ultimately con-
verted into cancer cells. A partial explanation is that the
majority of DNA lesions induced by exposure of mam-
malian cells to genotoxic agents, like X-rays, are more
lethal than mutagenic, although other agents such as the
alkylating agent ethyl methane sulfonate cause DNA
lesions which, at equal level of survival, are considerably
moremutagenic in the same kind ofmammalian cells than
X-ray-induced DNA lesions (2). Furthermore, when DNA
lesions form mutations, these are not necessarily those
that lead to cancer.
Another explanation for the difference in the mutagenic
potency of genotoxic agents is variability in the fidelity
with which individual DNA lesions in cells are repaired.
The vital role ofDNArepair in the etiology ofcancerwas
first established by Cleaver (3), who found that cells4rom
patients with the hereditary, cancer-prone disease xero-
dermapigmentosum (XP) had defectiverepairofultravio-
let radiation (UV)-induced DNA damage. XP is an
autosomal recessive disorder occurring at a frequency of
about 1-10 per106 individuals. Patients sufferingfromthis
disease have a greater chance of developing neoplasia on
parts of the body that are exposed to solar radiation. In
several other genetic diseases there is increased suscep-
tibility to DNA damaging agents; these include ataxia
telangiectasia, Fanconi's anemia, Bloom's syndrome,
Cockayne's syndrome, and trichothiodystrophy. The first
three diseases are also associated with an increased inci-
dence ofcancer, but the other two are notably not. On the
basis of these observations it can be hypothesized that
either a) not all DNA lesions lead to neoplastic transfor-
mation or b) the existence of high-fidelity DNA repair
processes is an essential prerequisite for preventing
tumor formation.LOHMAN ET AL.
Prediction of the Carcinogenic/
Mutagenic Potency of a Chemical
Weight-of-Evidence Evaluation and
Interpretation of Results from Short-Term
Tests for Genotoxicity
Over the past 20 years, the genotoxic activity ofchemi-
cals has been assessed typically by conducting a series of
short-term tests using various organisms. Most of these
tests were designed to be rapid and comparatively inex-
pensive; some were proposed as surrogates for rodent
carcinogenicity or rodent germ-cell bioassays. It is clear,
however, thatthe endpoints and targetcellsused in short-
term assays are dissimilar to the phenomena of car-
cinogenesis and germ-cell mutation. The notion that the
universe of chemicals is dichotomous toward the carcino-
genic/mutagenicpotential ofindividual chemicals hasbeen
theled tothedevelopment oftier orbatteryapproaches for
determining genotoxic properties in short-term assays. A
weight-of-evidence approach to the analysis of a large
database ofshort-termtestresults showed an almosttotal
absence of results indicating a division of the chemical
universe into mutagenic and nonmutagenic chemicals (4-
6). Rather, genotoxicity appears to be a consistent prop-
ertythroughoutthis universe. The genotoxicity ofachem-
ical can be expressed in terms of a so-called genotoxic
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FIGURE 1. Ranking of the genotoxic potential of chemical agents accord-
ing to their agent scores, calculated as described by Mendelsohn et al. (5).
The agent scores of the chemicals listed in Table 1 are numbered and
shown with the standard deviation; other agent scores (+) are those of
genotoxic agents described by Lohman et al. (4).
Thble 1. Hazardous halogenated organic air pollutants.
No. Saa
1 -24.28
2 -16.67
3 -15.27
4 - 13.58
5 -13.48
6 - 7.29
7 - 7.22
8 - 6.18
9 - 5.06
10 - 2.70
11 - 2.38
12 - 2.34
13 - 0.76
14 1.09
15 1.38
16 3.14
17 3.58
18 4.58
19 4.87
20 5.71
21 6.37
22 6.60
23 9.95
24 18.67
25 20.66
SD
17.17
12.11
9.56
23.86
11.57
14.90
17.80
15.47
6.93
25.02
12.62
11.96
15.20
14.54
12.49
19.90
14.53
17.02
16.90
12.26
12.47
19.50
10.87
16.20
23.73
Chemical
Tetrachloroethylene
Polychlorinated biphenyls
Chloroform
Dichloromethane
1,1,1-Trichloroethane
Bromoform
2,4,6-Trichlorophenol
Carbon tetrachloride
Heptachlor
Hexachlorocyclohexane
Vinylidene chloride
Trichloroethylene
Vinyl chloride
Pentachlorophenol
2,3,7,8-TCDD
2,4-D
Benzyl chloride
1,2-Dichloroethane
Dimethylcarbamoyl chloride
Dibromochloropropane
Methyl chloride
Ethylene dibromide
Epichlorohydrin
Chloroprene
Methyl bromide
CAS no.
127-18-4
1336-36-3
67-66-3
107-06-2
71-55-6
75-25-2
88-06-2
56-23-5
76-44-8
58-89-9
75-35-4
79-01-6
75-01-4
87-86-5
1746-01-6
94-75-7
100-44-7
107-06-2
79-44-7
96-12-8
74-87-3
106-93-4
106-89-8
126-83-9
74-83-9
CAS, Chemical Abstracts Service Registry number.
aSa, agent score according to Mendelsohn et al. (5).
agent score, and awidevarietyofchemicals canberanked
in this way, using the results of short-term test with a
minimal number of end points in vitro and in vivo. This
approach is demonstrated in Figure 1 and Thble 1. It has
been applied to halogenated organic air pollutants identi-
fied under the Clean Air Act, amended in 1990, in the
United States. The results contradict the hypothesis that
the mutagenicity ofchemicals can be divided into a simple
positive/negative dichotomy. Theyalso demonstrate that a
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FIGURE 2. Relationship between the carcinogenic potency in rodents
(medianTD50estimate,expressed aslifetime doseinmg/kgbodyweight)
ofmonoalkylating agents and their nucleophilic selectivity [Swain-Scott
constant, s (8)]. ENU, N-ethyl-N-nitrosourea; EO, ethylene oxide;
DDVP, 2,2-dichlorovinyldimethylphosphate.
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Table 2. s-Values, ratios ofring-X loss (CA) to recessive lethal mutations (RL) and TD50-values for a series of15 genotoxic agents.
Chemical CAS no. s CA/RL TD50 Classification
N-Nitrosodiethylamine 55-18-5 <0.04 56 Monofunctional
Dacarbazine 4342-03-4 0.42 0.06 684 Monofunctional
Procarbazine, Natulan 366-70-1 0.42 <0.14 262 Monofunctional
N-Nitrosodimethylamine 62-75-9 <0.16 139 Monofunctional
1-Phenyl-3,3-dimethylitriazene 7227-91-0 0.22 0.18 1580 Monofunctional
1-(2,4,6-Trichlorophenyl)-3,3-dimethyltriazene 0.29 0.42 7000 Monofunctional
1,2-Dibromoethane 106-93-94 1.2 0.37 1650 Monofunctional
Mitomycin C 59-07-7 0.81 1.14 0.68 Cross-linking
Thio-TEPA 52-24-4 1.10 2.83 131 Cross-linking
Busulfan 55-98-1 0.90 5.43 <140 Cross-linking
Cisplatin 15663-27-1 6.79 20 Cross-linking
Cyclophosphamide 79-19-4 8.54 2080 Cross-linking
Hexamethylphosphoramide 680-31-9 11.97 27 Cross-linking
TEPA 14.60 110 Cross-linking
2-Chloroacetaldehyde 107-20-0 1.3 19.00 13,000 Cross-linking
CAS no., Chemical Abstracts Service Registry Number.
ranking of the genotoxic potential of halogenated air
pollutants is possible; however, whether this genotoxic
potentialalsoreflectsthecarcinogenicpotential ofachem-
ical needs further evaluation.
Structure-Activity Relationships
Not only short-term tests but also the physicochemical
properties of a chemical have been used to predict its
relative genotoxic potential. This approach has been
especially successful for a range ofsimplemonofunctional
alkylating agents, such as N-ethyl-N-nitrosourea, eth-
ylene oxide, and2,2-dichlorovinyldimethyl-phosphate. The
way in which these compounds react with DNA can be
describedbytheirnucleophilic selectivity, as expressedby
the Swain-Scott s value. As first described by Barbin and
Bartsch (7), a relationship exists between the s value and
the carcinogenic potency of monoalkylating chemicals in
rodtnts (median TD50 estimates). That study was
extended byVogel et al. (8), and alimited summary ofthe
dataobtainiedbythoseinvestigatorsispresentedinFigure
2. For the monofunctional alkylating agents studied, the
relationship depicted in Figure 2 holds not only for
nucleophilic selectivity but also for the initial N7-alkyl-
guanine/06-alklyguanine ratio in DNA. Those observa-
tions indicate that the modifications at base oxygens in
DNA by monoalkylating agents are key DNA lesions for
determining their carcinogenic potency in rodents (8).
The relationship shown in Figure 2 was notfoundwhen
polyfunctional alkylating agents were studied. Polyfunc-
tional alkylating agents possess more than one active
ligand that can react with nucleophilic centers in DNA.
These agents, including a considerable number of anti-
tumor drugs such as cisplatin and cyclophosphamide, can
cross-link DNAstrands. AsVogel et al. (8) describe, their
carcinogenic potential is not directly related to their
nucleophilic selectivity(seealsoTable2)buttotheirability
to cross-link DNA, with the possible exception of cross-
linking agents with a very high s value. Agents such as
2-chloroacetaldehyde (Table 2) have such ahighaffinityto
other macromolecules (e.g., proteins) present in cells and/
or body fluids that hardly any damage to DNA occurs.
Therefore, DNA is not the main target and these agents
have low carcinogenic potency.
The cross-linking property appears to be the main
determinant of the low TD50 of polyfunctional car-
cinogens. Interestingly, the group of cross-linking com-
pounds can be recognized relatively easily by their high
efficiency in inducing clastogenic effects in cells. The
relative clastogenic efficiency of genotoxic agents can be
determined in the fruit fly, Drosophila melanogaster, by
measuringtheratioofinducedring-Xloss (achromosomal
damageendpoint,CA)tosex-linkedrecessivelethalmuta-
tions (RL) (CA/RL). Compounds with a CA/RL ratio
greaterthan about1.2 arelikelytobe cross-linking agents
(8) (Table 2). Thus, this method has prognostic value for
discriminating monofunctional alkylating agents from
those with cross-linking properties.
Processing of DNA Damage in Human
Cells
Mechanisms ofDNA Repair
Amammalian cell contains about 50 cm ofDNA, which
has to be reduced some 50,000 times in size to fit into the
cell nucleus. Although not always recognized it is obvious
that the processes behind DNA repair are strongly influ-
encedbytheorganizationofthenucleusinthecell. Consid-
erable evidence is nowavailable to suggest thatregions of
the chromatin that are engaged in DNA replication and
transcription are in a more open configuration than the
bulkofthechromatin.Thenonrandomnessofthefunction-
ingofDNArepairprocesses and, ultimo, the alteration of
DNA(i.e.,mutations) canberecognized atleastthelevelof
the chromatin, the individual genes, the DNA strand in
genes activelyinvolved intranscription ofRNA, and atthe
individual type ofDNA damage.
The complexity of DNA damage processing can be
demonstrated in experiments in which normal human
fibroblasts and fibroblasts from patients with the DNA
repair-deficient syndrome XP complementation group C
(XP-C) are exposed to low doses of 254 nm UV. At the
chromatin level, the DNAis organized inloops attached to
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FIGURE 3. Matrix-, gene-, and DNA strand-specific DNA repair in normal human fibroblasts and fibroblasts from xeroderma pigmentosum,
complementation group C, patients (XP-C) after exposure to 5J/m2 254 nm ultraviolet light (UV). (A) Excisionrepair ofDNA atthe nuclearmatrix and
chromatin loops 60 min after exposure to UV. (B) Removal ofcyclobutane pyrimidine dimer (CPD) from an active housekeeping gene and an inactive
X-chromosomal DNA sequence (754) 4 hr after exposure to UV. (C) Removal ofCPD from the transcribed and nontranscribed DNA strand ofthe ada
gene 24 hr after exposure to UV.
a nuclear matrix. As depicted in Figure 3A, we found that
in normal human fibroblasts exposed to 5 J/m2 UV, DNA
repair closely associated with the nuclear matrix was
approximately 2-fold more frequent than in loop DNA.
Although XP-C exhibited only 15% residual DNA repair
compared to wild-type cells, DNA repair activity at the
nuclear matrix was about four-fold greater than in loop
DNA (9,10). This finding indicates that in human cells
different DNArepair mechanisms are associated with the
functional status ofthe chromatin.
Evidence exists that transcriptionally active DNA is
associated with the nuclear matrix. A DNArepair mecha-
nism associated with transcriptionally active DNA was
identified by measuring removal of the (UV-induced)
cyclobutane pyrimidine dimer (CPD) from the active ade-
nosine deaminase (ada) housekeeping gene and an inac-
- Nuclear Matrix Repair
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tive X-chromosomal sequence designated 754 (located in
the proximity of the Duchenne's muscular dystrophy
gene) in human cells. As shown in Figure 3B, CPDs are
repaired more quickly in active housekeeping genes than
ininactive genes orin the (bulk) total DNAofthe genome.
XP-C cells can efficiently repair active genes but are
defective in repairing CPD in transcriptionally inactive
DNA (11).
The relationship between aspecific DNArepairprocess
and RNAtranscription in active genes was further elabo-
rated by studying the repair of CPD in the transcribed
andnontranscribed DNAstrandintheadageneofnormal
and XP-C fibroblasts [Figure 3C (12,13)]: XP-C cells effi-
ciently repaired the transcribed DNA strand but were
inhibited from repairingthe nontranscribed DNAstrand.
The fourth level at which different DNA repair pro-
cesses operate in human and other mammalian cells is at
thekind oflesionthatisinducedin DNA. Discussions have
been going on for many years about which is the most
significant lesion (key lesion) for mutagenesis in mam-
malian cells after exposure to UV. The two majortypes of
DNA lesion induced by UV are CPD and the 6-4
pyrimidone photoproduct. Zdzienicka etal. (14) found that
a revertant ofthe UV-sensitive Chinese hamster cell line
VH1, which has similar mutation induction frequencies as
wild-type cells after exposure to UV exhibits complete
deficiency in dimer removal from the X-chromosomal
hypoxanthine phosphoribosyl transferase (hprt) gene and
a normal level of 6-4 pyrimidone photoproduct repair in
thegenomeoverall.ThelevelofUV-inducedmutationswas
similar to that found in normal cells, which indicates a
minor role for dimers in mutagenesis; however, this may
notbe a general rule for all cell types from all mammalian
species. The main conclusion is that different repair pro-
cesses and/or different efficiency in the DNA repair pro-
cess exist for different DNA lesions and that this may
influence strongly which DNA damage can be considered
to be the key lesion for mutation induction after exposure
to a genotoxic agent. Of course, this still leaves open the
ENU Induced
(20.2)
brain
question of whether a DNA lesion for which no repair
process existswithin cells shouldbeconsideredtobe akey
lesion for possible adverse biological effects.
Organ- and Tissue-Specific
Carcinogenesis/Mutagenesis
Thmor formation in both rodents and humans after
exposure to genotoxic agents commonly occurs in specific
organs and tissues. This mayindicate that several groups
of precarcinogens need metabolic activation and that
activation differs in the various organs of the body. The
organ and tissue specificity of tumor formation by many
other genotoxicants, which are capable of inducing DNA
lesions in all cells ofthe body, is still not understood.
Few methods are available to study the organ- and
tissue-specific effects of DNA lesions in vivo, but trans-
genic mouse model systems have been proposed recently
whichallowstudyofmutations invivo (15,16). Oneofthese
strains of transgenic mice harbors multiple copies of a
bacteriophage A shuttlevector containing the prokaryotic
lacZgene (AgtlOLacZvector), integratedin ahead-to-tail
arrangement in the genome, which provides a target for
mutagenesis in all organs and tissues of the transgenic
animal (17). The integrated vectors can be rescued from
total genomic DNA with high efficiency by packaging in
vitro and theinduction ofmutations can be analyzed after
propagation of the phages in a LacZ- strain of the
bacterium Escherichia coli C (18). Several strains of
transgenic mice havebeenproduced, eachwith a different
number ofshuttle vectors at a different integration site in
the genome (17).
In Figure 4, an example is given of the induction of
mutations in the brain and liver of the strain 20.2 trans-
genic mouse (80 copies of the XgtlOLacZ vector on an
autosomal chromosome), after exposure to the directly
acting DNA alkylating agent N-ethyl-N-nitrosourea.
After administration of 250 mg/kg body weight of the
alkylating agent, the mutation frequencies in brain cells
Spontaneous
(liver)
35.5
40.6
20.2
liver
FIGURE 4. Induction ofmutations in the AgtlOLacZ vector in transgenic mice. (Left) Relative number ofmutations induced in the brain and liver of
strain 20.2 after exposure to 250mgN-ethyl-N-nitrosourea (ENU) perkgbodyweight. Mutation induction was analyzed 7 days after treatment with
ENU (mutationfrequency: braincells, 7.1 x 10- livercells, 2.1 x 10-5).(Right)Spontaneous mutationfrequenciesintheDNAoflivercellsfromthree
transgenic mouse strains (20.2: 80copies, autosomal, mutation frequency0.1 x 10-5; 40.6: 35copies, autosomal, mutation frequency0.7 x 10-5 35.5:
15 copies, X-chromosomal, mutation frequency 15.5 x 10-5).
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appeared tobethreetimesgreaterthanthoseinlivercells
from the same animal. Since in this case the vectors were
isolated from postmitotic brain tissue ofadult transgenic
mice, DNAreplication had nottakenplace after exposure,
and the observed mutation may have been the result ofan
on-going error-prone DNA repair process in nondividing
cells. This experiment shows that even after exposure to a
directly acting agent like N-ethyl-N-nitrosourea, which
induces asimilarkind and similar amounts ofDNAlesions
in all cells of the body, there is a striking difference in
mutation induction in different organs.
Ofcourse, itmustbe realized thatthe XgtlOLacZ vector
is heavily methylated in vivo and should be considered an
inactive gene; no information can be given on the possible
differential response of mutation induction in an active
housekeepinggene. Still, this kind ofexperiment provides
a first approach to mechanistic studies at the organ and
tissue level in an individual mammal. Recently, Gossen et
al. (19) provided evidence that the integration site of the
vector is an important parameter in the occurrence of
spontaneous mutations. They found that the background
mutation frequencies in three transgenic mouse strains
(20.2: 80 copies, autosomal; 40.6: 35 copies, autosomal;
35.5:15copies,X-chromosomal)variesconsiderably. Espe-
cially noteworthy was the high spontaneous mutation fre-
quency in cells of the liver (and also the brain) of strain
35.5 (Fig. 4). These results indicate that the mutability of
genespresentinthegenome ofmammaliancellsisnotuni-
form and, therefore, clearly indicates the presence ofmu-
tational "hot spots" in the genome ofsomatic cells in vivo.
A
Biomonitoring Exposure to Genotoxic
Agents in Human Populations
Cytogenetics
It is generally recognized that chromosomal changes
are associated with the process of tumor development.
Although the molecular basis for the relationship between
specific chromosomal changes and cancer is not well
understood in all cases, cytogenetics is one of the most
frequently used methods to establish human exposure to
mutagens and/or carcinogens. Conventional techniques
formeasuringchromosomalchangesrequirethatthe cells
(in humans, usually stimulated peripheral blood lympho-
cytes) beproliferating, so thatchromosomes ininterphase
canbeseenatmitosis orasmicronuclei(20).This,however,
limits application of this approach to a specific class of
cells.
A method for studying chromosomal aberrations in
nondividing cells has been improved and made available
forscreeningoflargehumanpopulations.Thisinvolvesthe
technique ofpremature chromosome condensation (PCC);
i.e., when mitotic cells are fused with interphase cells, the
nuclei of the interphase cells undergo an immediate pro-
phaselike reaction, such that the nuclear envelope is dis-
assembled and the chromatin condensed into chromo-
somes (Fig. 5). This technique allows sensitive monitoring
ofaccumulation ofchromosomaldamageinslowlydividing
or nonproliferating cell populations of human origin. The
sensitivity ofthe PCC method in comparison with that of
B
FIGURE 5. Prematurely condensed chromosomes obtained from fusion between a human interphase T-cell and a Chinese hamster ovary mitotic cell. A
differential staining technique makes the prematurely condensed chromosomes dark and the mitotic chromosomes light. (A) Prematurely condensed
chromosomes from control human T-cells; (B) prematurely condensed chromosomes from human T-cells irradiated with 8 Gy ofX-rays.
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FIGURE 6. Inductionofchromosomal breaksinhumanlymphocytes after
irradiation with X-rays in vitro. The breaks were measured by the
prematurely condensed chromosome method in nondividing cells 1 hr
after irradiation (hatched bars) and in metaphase preparations ofstimu-
lated, dividing cells 48 hr after irradiation (solid bars).
classical detection of chromosomal breaks in metaphase
preparations is demonstrated in Figure 6. In this experi-
ment, human lymphocytes were irradiated with various
doses of X-rays, and chromosomal breaks were scored
using the PCC method 1 hr after irradiation and as
chromosomal fragments in stimulated irradiated cells 48
hr after irradiation. As can be concluded from the data
shown in Figure 6, the PCC method is about10 times more
sensitive than the classical method of scoring chromoso-
mal fragments.
The PCC technique is also useful for monitoring
responses to therapeutic treatment of malignant tumors
(21). In principle, it will even be possible to study partial
body irradiation due to occupational and/or accidental
exposures. The cytogenetic damage in the fraction of
exposed cells present among a huge number of normal
cells can be detected with PCC. This was shown in a
reconstruction experiment in which human lymphocytes
were irradiated with X-rays (8 Gy) and mixed with a
specified amount of un-irradiated cells (Table 3). Subse-
quently, the human cells were fused with mitotic Chinese
hamster cells, and chromosomal fragments (PCC) were
scored in individual cells; thus the fraction of damaged/
undamaged cells in themixedpopulation canbe accurately
calculated. The PCC method is sensitive enough to detect
the presence ofonly 3% unirradiated cells in a population
Table 3. Chromosomal damage in human lymphocytes after 8 Gy of
X-rays as measured by premature chromosome condensation.
Damaged cells No. of cells No. ofcells Damaged cells
(initial), % scored damaged (measured), %
0 156 0 0.0
10 100 13 13.0
30 91 26 28.6
50 46 18 39.1
70 55 41 74.5
80 56 46 82.1
90 57 51 89.5
95 48 45 93.8
97 52 51 98.1
99 45 45 100.0
100 79 79 100.0
of 97% irradiated cells (Table 3). This suggests that the
extent of partial body irradiation in vivo could be accu-
rately determined by the PCC method.
Molecular Dosimetry ofDNA Lesions
Approaches for using DNA lesions as a basis for elu-
cidating dose-response relationships in carcinogen-
exposedhumansandanimalshavebeendevelopedthrough
molecular dosimetry. In comparison with approaches
based on external exposure, molecular dosimetry offers
the distinct advantage of being capable of integrating
dose-dependent differences in absorption, distribution,
biotransformation, and DNArepair, allowingthe determi-
nation of exposures to carcinogens more accurately and
over a wide range of doses (22). Molecular dosimetry in
vivo, especially in humans, is complicated by a number of
factors, the major one being that DNAlesions are formed
inrelatively small quantities, at anupperlimit ofabout100
fmole/,g DNA [< 3 DNA lesions per 105 "normal" DNA
nucleotides (23-25)]; in humans, often levels down to 3
DNA lesions per 107 "normal" nucleotides are often com-
mon.
Samples of human target tissues cannot be collected
routinely, and surrogates (like DNAfrom nucleated blood
cells) must be used. As long as there is a parallel between
the level of DNA lesions in target and surrogate tissues,
the lattercan be used as ameasure oftheformer. Another
possible surrogate as anindicator ofDNAdamagemaybe
protein damage: use of hemoglobin adducts as a dose
monitor for alkylating and arylating genotoxic agents has
been developed successfully by the group of Ehrenberg
[(26) for further references, see Ehrenberg (27) and Neu-
mann (28)]. The existence ofalinearrelationship between
the levels of DNA lesions and of the carcinogen in the
environment or absorbed into the body will, of course,
facilitate such a comparison. Such parallels and linear
relationships have been observed in experimental animals
and are indicated in man, but cannot be generalized (29).
Two techniques-immunoassays to measure the pres-
ence ofspecific DNA adducts and 32P-postlabeling-have
found general utility for detection of DNA lesions in both
experimental animals and humans. In the immunological
approach, monoclonal or polyclonal antibodies are raised
against either carcinogen-modified DNA or carcinogen-
nucleoside DNA lesions (adducts) coupled to protein car-
riers. The antibodies are then used to quantify specific
adducts in the DNA of exposed cells. In the 32P-post-
labeling method, some DNA adducts can be detected at a
level approaching one adductin about1010 "normal" nucle-
otides (at least 10-100 times more sensitive than compar-
able immunochemical techniques). A major problem with
the 32P-postlabeling method is, however, identification of
the observed adducts. Adducts to hemoglobin and serum
albumin are the only protein adducts so far used for
molecular dosimetry in human samples. Protein adducts
are not repaired and have a relatively slow turnover rate,
which allows detection of accumulated damage. Further-
more, protein samples are generally available in much
larger quantities than DNA samples in vivo, allowing a
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FIGURE 7. Induction of DNA alterations in the hprt gene ofmutant human T-cell clones derived from blood. DNA base substitutions in mutant hprt
clones ofhumanT-cellsfromnormal, healthydonors (controls),individuals occupationally exposed tovaryingdoses ofethyleneoxide, andfromsmokers.
more sensitive approach to molecular dosimetry [for
reviews of DNA and protein adducts, see Lohman et al.
(24) and Wogan (29)].
Gene Mutation and Spectral Analysis of
DNA Alterations in Mutated Genes
Differentgenotoxic agentsinduce differentDNAlesions
in exposed cells, and the DNA alterations that result from
those lesions varywith different agents. This spectrum of
DNA alterations can be measured, for instance, in the
endogenous hprt gene (located on the X-chromosome) of
preselected mutant T-cells from the peripheral blood of
exposed people.
Molecular analysis of DNA alterations in individual
genes became possible after introduction of the poly-
merase chain reaction technique by Mullis et al. (30).
Vrieling et al. (31,32) adapted this technique for the anal-
ysis of DNA alterations in the hprt gene of mammalian
cells. For this purpose, cDNA derived from hprt mRNA
from an expressed mutant gene is amplified and se-
quenced; bycomparison with the known DNA sequence of
the wild-type hprt gene, it is possible to determine which
DNA alteration has been induced in the mutant gene.
Figure 7 shows an example of the spectrum of DNA
alterations found in hprt T-cell mutants isolated from the
blood of normal, healthy people (background mutation
spectrum; controls in Figure 7), in people occupationally
exposed to high concentrations of ethylene oxide, and in
smokers. Only the spectra of DNA base alterations are
given; information can also be obtained on the occurrence
of deletions, frameshifts, or base insertions in the hprt
gene. The spectrum of DNA base alterations in the hprt
gene alreadyshows clearlythatthebackground spectrum
ofDNAalterationsis differentfromthatofexposedpeople
and that differences also occur depending on the agent.
The spectrum of DNA alterations in mutant T-cells from
smokers, for instance, is missing the class of GC to TA
DNA base transversions, which is present in background
mutations and to a lesser extent in mutated cells from
people exposed to ethylene oxide (Fig. 7). The observation
that the spectrum ofmutations scored in the hprt gene of
mammalian cells is unique for each genotoxic agent sug-
gests that spectral analysis of DNA alterations, as mea-
sured in mutant T-cell clones, may be used in biomonitor-
ing to indicate the kind ofagents or mixtures ofagents to
which a population is exposed.
DNA Fingerprinting the Human Genome
Analysis ofmutations or spectra ofmutations in single
endogenous genesin,forinstance, humanT-cellcloneswill
notin most cases be sufficientforriskestimation, because
the end point studied may not reflect the key event(s)
leading to carcinogenesis. Alternative techniques are
probablyrequired to studyun-selected mutationinduction
intargetcells ortoanalyzemutationsinkey genes, such as
oncogenes. Itis expected thatthe field ofDNAtechnology
will provide the tools for such analyses. A preliminary
approach is analysis ofunselected mutations in the human
genome using the DNA fingerprinting technique.
The human genome is estimated to contain several
thousand micro- and minisatellite DNA sequences, which
are spread more or less evenly over the chromosomes.
Together, these sequences roughly compose about 1% of
the total number ofbase pairs. It has been demonstrated
that a fraction of these sequences [the so-called variable
numberoftandemrepeats (VNTR) sequences] represents
a relatively unstable part of the human genome during
mitosis and/or meiosis (33). As a result, these sequences
usually display extensive allelic variation in the human
population. In view of their high copy number and their
allelic variability, VNTRs can also serve as a genetic
marker of such instability in the total genome. By using
core probes, different sets of micro- and minisatellites,
each consisting of several hundred loci (including VNTR
loci), can be detected by Southern blot hybridization anal-
ysis. This process is also known as DNA fingerprinting.
In order to resolve DNArestriction fragments contain-
ingmicro-andminisatellite sequences, twoelectrophoretic
methods can be employed. Southern blot hybridization
analysis encompasses the one-dimensional resolution of
about 20-30 relatively large fragments (2-20 kb), while
two-dimensional DNAfingerprinting canresolvevirtually
allmembersofaparticularsetofmicro-andminisatellites.
Using these two DNAfingerprinting techniques, the gen-
ome can be scanned for variations in micro- and mini-
satellite DNA sequences. Using this approach, it is
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FIGURE 8. Two-dimensional DNAfingerprint oftwo clones (M and R) ofthe humanlymphoblastoid TK6 cell line. Before isolation, theparent TK6 cells
were irradiated with 0.54 Gy X-rays. A single mutant allele was found in clone R (arrow).
possible to measure human mutation rates at multiple sites
dispersed through the genome (34,35).
In order to investigate the sensitivity of the DNA
fingerprinting methods for the detection of DNA rear-
rangements and deletions, experiments were performed
with the established human lymphoblastoid TK6 cell line.
Independent TK6 clones were analyzed after X-irradia-
tion in one- and two-dimensional gels (using the core probe
33.1.1. and Haelll as the restriction enzyme). After two-
dimensional analysis of TK6 clones, an additional change
was deteeted by comparing the DNA fingerprint of clones
M and R; a single mutant allele (out of 550 analyzed) was
observed (Fig. 8). Because few experiments have been
done so far, however, this mutant allele may not have been
induced by X-rays, but may due to the presence of mutant
subpopulations in the stock culture. This problem is
especially pertinent for the established lymphoblastoid
cell line TK6, which has been cultured for many cell
generations; it is, therefore, not surprising to detect the
presence of subpopulations within the cell culture. The
experiment demonstrated, however, that DNA alterations
can be observed in unselected, randomly picked clones of
cells of human origin.
Epidemiology and Risk Assessment
The main accomplishment of the past 20 years in the
field of environmental and occupational monitoring of
exposure to carcinogenic agents has been the development
of methods for detecting qualitatively the genotoxic poten-
tial and, therefore, the possible carcinogenic potential of
individual agents. The main deficiency has been that,
neither in an absolute sense nor relatively in comparing
chemicals, can a quantitative estimate be made of the
carcinogenicpotential ofanagentforhumans. Ofcourse, a
limited number of agents are known to be human car-
cinogens;however, thisknowledgeisfarfromsufficientfor
estimating the total carcinogenic potential ofthe universe
of chemicals to which humans are exposed.
In human populations, the ad-hoc approach for deter-
mining the carcinogenic potency of a chemical will always
fail, except in the rare cases in which a chemical is a
carcinogen at any concentration, if the selection criteria
forconsidering the chemical are based on nothing else but
relative genotoxic potential, the amount and effectiveness
ofexposure, and mechanism ofaction. For a limited group
of chemicals -the monofunctional alkylating agents -
enough knowledge seems to be available to allow determi-
nation ofrelative genotoxicpotential, to measure exposure
to individual chemicals in a population, and, at least for
directly acting agents, to allow a quantitative risk assess-
ment. The bestexample so faris that developed by Ehren-
berg: exposure of a human population to ethylene oxide
using the radiation dose equivalent approach [for review,
see Wright et al. (36)].
Because of the complexity of the situation, there is an
increasing need in epidemiology for reliable, sensitive
techniques to monitor exposure of human populations to
mixtures of potential genotoxic agents. Although signifi-
cant progress has been made in detecting DNA damage,
DNA alterations, and mutations in vivo, the methods are
often still too cumbersome to be applied to large popula-
tions and are restricted to a limited group ofchemicals.
The striking organ and tissue specificity of known
carcinogens in both experimental animals and humans
should command considerable attention in the coming
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years. Thehypothesis thatkeyDNAlesionswilldetermine
whether a chemical is an organ- or tissue-specific car-
cinogen maystill bevalid. Unfortunately, however, there is
evidence that such key lesions may be different for differ-
entchemicals. So, more knowledge mustbe collected about
the mechanism ofcarcinogenesis, beyond the formation of
DNA lesions, before a rational approach can be evolved to
identify specific or groups of key DNA lesions.
This manuscript was presented at the Conference on Biomonitoring
and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona,
Hawaii, 26 October-1 Novenmber 1991.
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Science Institute, Washington, DC. The help and comments of A. G.
Uitterlinden and J. A. Gossen, Medscand-INGENY, Leiden, The Nether-
lands, during preparation of the manuscript are gratefully acknowl-
edged. The computerized data file on the genotoxic properties of
halogenated organic air pollutants was obtained through M. Waters and
F. Stack, Environmental Protection Agency, Research Triangle Park,
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